These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37813239)
1. Visual and semi-quantitative analysis of 6-[ Suárez-Piñera M; Rodriguez-Bel L; Alemany M; Pons-Escoda A; Pudis M; Coello A; Reynes G; Vidal N; Cortes-Romera M; Macia M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):6-13. PubMed ID: 37813239 [TBL] [Abstract][Full Text] [Related]
2. Identify glioma recurrence and treatment effects with triple-tracer PET/CT. Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015 [TBL] [Abstract][Full Text] [Related]
3. Differentiating high-grade glioma progression from treatment-related changes with dynamic [ Rozenblum L; Zaragori T; Tran S; Morales-Martinez A; Taillandier L; Blonski M; Rech F; Galanaud D; Kas A; Verger A Eur Radiol; 2023 Apr; 33(4):2548-2560. PubMed ID: 36367578 [TBL] [Abstract][Full Text] [Related]
5. Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma. Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Goenka A; Gupta DK; Malhotra A; Bal C Eur Radiol; 2013 Sep; 23(9):2628-35. PubMed ID: 23624623 [TBL] [Abstract][Full Text] [Related]
6. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study. Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944 [TBL] [Abstract][Full Text] [Related]
7. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081 [TBL] [Abstract][Full Text] [Related]
8. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and grading accuracy of Xiao J; Jin Y; Nie J; Chen F; Ma X BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Gupta DK; Malhotra A; Bal C Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498 [TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study. Karunanithi S; Bandopadhyaya GP; Sharma P; Kumar A; Singla S; Malhotra A; Gupta DK; Bal C Clin Nucl Med; 2014 Feb; 39(2):e121-8. PubMed ID: 23579970 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420 [TBL] [Abstract][Full Text] [Related]
15. Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Herrmann K; Czernin J; Cloughesy T; Lai A; Pomykala KL; Benz MR; Buck AK; Phelps ME; Chen W Neuro Oncol; 2014 Apr; 16(4):603-9. PubMed ID: 24305722 [TBL] [Abstract][Full Text] [Related]
16. Early Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961 [TBL] [Abstract][Full Text] [Related]
17. Adrenal tracer uptake by Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769 [TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases. Lizarraga KJ; De Salles AA; Chen W Expert Rev Med Devices; 2014 Jul; 11(4):327-9. PubMed ID: 24894391 [TBL] [Abstract][Full Text] [Related]
19. Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased Somme F; Montaz-Rosset MS; Averous G; Deur J; Goichot B; Bachellier P; Addeo P; Imperiale A Clin Endocrinol (Oxf); 2020 Jul; 93(1):78-81. PubMed ID: 32314437 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of adrenal masses using 18 F-FDOPA PET/CT in patients suspected with pheochromocytoma. Kim SJ; Park CY; Kwon H; Kim YH Nucl Med Commun; 2024 Jan; 45(1):86-92. PubMed ID: 37901929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]